45 Healthcare Stocks Moving In Monday's After-Market Session

Gainers

  • Medpace Hldgs, Inc. MEDP shares increased by 10.8% to $74.99 during Monday's after-market session. The market cap stands at $2.4 B.
  • Neurocrine Biosciences, Inc. NBIX shares moved upwards by 9.8% to $95.45. The market cap stands at $7.9 B. According to the most recent rating by Guggenheim, on 2019-06-05, the current rating is at Neutral, with a price target of $88.00.
  • Hepion Pharmaceuticals, Inc. HEPA stock surged 7.7% to $3.50. The market cap stands at $5.3 M.
  • Xenetic Biosciences, Inc. XBIO shares surged 6.3% to $2.54. The market cap stands at $7.8 M.
  • Ocular Therapeutix, Inc. OCUL stock rose 5.9% to $5.00. The market cap stands at $202.1 M. According to the most recent rating by Cowen & Co., on 2019-05-21, the current rating is at Market Perform.
  • Atara Biotherapeutics, Inc. ATRA shares increased by 5.0% to $15.46. The market cap stands at $686.9 M. According to the most recent rating by Citigroup, on 2019-06-04, the current rating is at Neutral.
  • Tyme Technologies, Inc. TYME shares rose 4.5% to $1.17. The market cap stands at $125.3 M.
  • Rockwell Medical, Inc. RMTI shares surged 4.2% to $3.25. The market cap stands at $201.8 M. According to the most recent rating by Cantor Fitzgerald, on 2019-06-25, the current rating is at Overweight, with a price target of $11.00.
  • Veru, Inc. VERU stock surged 4.0% to $2.32. The market cap stands at $140.0 M. According to the most recent rating by Cantor Fitzgerald, on 2019-07-02, the current rating is at Overweight, with a price target of $6.00.
  • Obalon Therapeutics, Inc. OBLN stock moved upwards by 3.6% to $6.65. The market cap stands at $22.8 M.
  • SINTX Technologies, Inc. SINT shares surged 3.2% to $3.20. The market cap stands at $2.2 M.
  • Viveve Medical, Inc. VIVE stock moved upwards by 3.1% to $0.16. The market cap stands at $7.0 M. According to the most recent rating by Ladenburg Thalmann, on 2019-07-24, the current rating is at Neutral.
  • Cellectar Biosciences, Inc. CLRB stock rose 2.8% to $2.20. The market cap stands at $20.1 M. According to the most recent rating by H.C. Wainwright, on 2019-05-02, the current rating is at Buy, with a price target of $4.00.
  • Coherus BioSciences, Inc. CHRS shares surged 2.8% to $16.75. The market cap stands at $1.1 B. According to the most recent rating by Barclays, on 2019-06-11, the current rating is at Overweight, with a price target of $30.00.
  • MannKind, Inc. MNKD stock moved upwards by 2.7% to $1.13. The market cap stands at $206.5 M. According to the most recent rating by BTIG Research, on 2019-05-14, the current rating is at Buy, with a price target of $3.00.
  • Acasti Pharma, Inc. ACST shares increased by 2.6% to $2.75. The market cap stands at $210.0 M. According to the most recent rating by Oppenheimer, on 2019-07-18, the current rating is at Outperform, with a price target of $7.00.
  • Achillion Pharmaceuticals, Inc. ACHN shares rose 2.5% to $4.45. The market cap stands at $602.0 M. According to the most recent rating by Barclays, on 2019-05-03, the current rating is at Underweight, with a price target of $2.50.
  • Avrobio, Inc. AVRO shares surged 2.5% to $23.13. The market cap stands at $544.9 M. According to the most recent rating by Mizuho, on 2019-06-27, the current rating is at Buy, with a price target of $28.00.
  • Guardion Health Sciences, Inc. GHSI stock increased by 2.5% to $1.25. The market cap stands at $27.7 M.
  • Exact Sciences, Inc. EXAS shares rose 2.4% to $120.41. The market cap stands at $15.1 B.
  • Encompass Health, Inc. EHC shares surged 2.1% to $68.88. The market cap stands at $6.6 B. According to the most recent rating by BMO Capital, on 2019-06-27, the current rating is at Outperform, with a price target of $72.00.
  • Aptevo Therapeutics, Inc. APVO stock moved upwards by 2.0% to $0.86. The market cap stands at $38.0 M.
  • Aileron Therapeutics, Inc. ALRN stock increased by 1.9% to $0.54. The market cap stands at $14.3 M.
  • Sesen Bio, Inc. SESN shares moved upwards by 1.9% to $1.10. The market cap stands at $87.2 M. According to the most recent rating by H.C. Wainwright, on 2019-06-11, the current rating is at Buy, with a price target of $3.00.
  • Aphria, Inc. APHA shares moved upwards by 1.5% to $5.42. The market cap stands at $1.3 B. According to the most recent rating by CIBC, on 2019-07-26, the current rating is at Underperformer.

 

Losers

  • Alimera Sciences, Inc. ALIM shares fell 10.6% to $0.80 during Monday's after-market session. The market cap stands at $63.5 M. According to the most recent rating by Craig-Hallum, on 2019-05-28, the current rating is at Buy, with a price target of $3.00.
  • Evoke Pharma, Inc. EVOK stock decreased by 7.8% to $0.95. The market cap stands at $23.9 M.
  • BioDelivery Sciences Intl, Inc. BDSI stock plummeted 7.3% to $3.41. The market cap stands at $329.4 M.
  • Sientra, Inc. SIEN stock plummeted 6.6% to $5.55. The market cap stands at $292.3 M. According to the most recent rating by Wells Fargo, on 2019-06-05, the current rating is at Outperform, with a price target of $10.00.
  • Karyopharm Therapeutics, Inc. KPTI shares fell 3.9% to $8.31. The market cap stands at $526.4 M. According to the most recent rating by JP Morgan, on 2019-07-23, the current rating is at Overweight, with a price target of $16.00.
  • PerkinElmer, Inc. PKI shares plummeted 3.8% to $91.75. The market cap stands at $10.5 B. According to the most recent rating by Raymond James, on 2019-07-10, the current rating is at Outperform.
  • Marinus Pharmaceuticals, Inc. MRNS shares fell 2.6% to $1.12. The market cap stands at $60.4 M.
  • Jaguar Health, Inc. JAGX stock plummeted 2.3% to $1.72. The market cap stands at $9.7 M.
  • ACADIA Pharmaceuticals, Inc. ACAD shares declined 1.9% to $23.60. The market cap stands at $3.4 B. According to the most recent rating by Raymond James, on 2019-05-31, the current rating is at Strong Buy, with a price target of $43.00.
  • SELLAS Life Sciences, Inc. SLS stock fell 1.9% to $0.16. The market cap stands at $36.1 M.
  • Illumina, Inc. ILMN stock decreased by 1.7% to $299.30. The market cap stands at $44.7 B. According to the most recent rating by Bank of America, on 2019-07-12, the current rating is at Underperform.
  • Zynerba Pharmaceuticals, Inc. ZYNE stock fell 1.7% to $10.61. The market cap stands at $227.3 M.
  • AcelRx Pharmaceuticals, Inc. ACRX stock decreased by 1.5% to $2.56. The market cap stands at $205.1 M. According to the most recent rating by Credit Suisse, on 2019-07-10, the current rating is at Outperform.
  • Glaukos, Inc. GKOS stock decreased by 1.5% to $75.50. The market cap stands at $2.7 B. According to the most recent rating by BMO Capital, on 2019-05-09, the current rating is at Market Perform, with a price target of $71.00.
  • Omeros, Inc. OMER stock decreased by 1.4% to $15.10. The market cap stands at $751.0 M. According to the most recent rating by Cantor Fitzgerald, on 2019-05-06, the current rating is at Overweight, with a price target of $26.00.
  • Neuralstem, Inc. CUR shares declined 1.4% to $2.17. The market cap stands at $2.3 M.
  • Athersys, Inc. ATHX shares declined 1.3% to $1.48. The market cap stands at $224.6 M.
  • Silk Road Medical, Inc. SILK stock declined 1.1% to $44.00. The market cap stands at $1.3 B.
  • InflaRx, Inc. IFRX stock decreased by 1.0% to $2.86. The market cap stands at $75.0 M. According to the most recent rating by Baird, on 2019-06-06, the current rating is at Neutral, with a price target of $6.00.
  • Viking Therapeutics, Inc. VKTX stock decreased by 1.0% to $7.70. The market cap stands at $560.5 M. According to the most recent rating by Oppenheimer, on 2019-07-16, the current rating is at Outperform, with a price target of $12.00.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsMovers & ShakersAfter-Hours CenterMarketsMoversTrading IdeasGeneralBiotechnologyHealth CareHealthcare Stocks After-Market MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!